Analysts Are Bullish on Top Healthcare Stocks: Puma Biotechnology (PBYI), ESSA Pharma (EPIX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Puma Biotechnology (PBYI – Research Report) and ESSA Pharma (EPIX – Research Report) with bullish sentiments.

Puma Biotechnology (PBYI)

In a report released today, Edward White from H.C. Wainwright reiterated a Buy rating on Puma Biotechnology, with a price target of $8.00. The company’s shares closed last Tuesday at $6.33, close to its 52-week high of $6.41.

According to TipRanks.com, White ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -9.9% and a 34.3% success rate. White covers the Healthcare sector, focusing on stocks such as 60 Degrees Pharmaceuticals, Inc., Karyopharm Therapeutics, and Inhibikase Therapeutics.

Currently, the analyst consensus on Puma Biotechnology is a Moderate Buy with an average price target of $8.00.

See the top stocks recommended by analysts >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on PBYI:

• Biotech Alert: Searches spiking for these stocks today